학술논문
A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia
Document Type
Article
Author
Source
In Value in Health December 2016 19(8):1009-1015
Subject
Language
ISSN
1098-3015